- Privacy
- Clinical Trials
Clinical Trials
The protection of personal data is of high importance to Genmab and Genmab is committed to safeguard study subjects’ rights when Genmab handles their personal data as a sponsor of clinical trials.
Genmab is required to provide patients with sufficient and clear information about Genmab’s use of their personal data collected during their participation in the Genmab clinical trials in order to ensure transparency about how Genmab handles personal data collected for the study purpose and to properly inform study subjects of their rights towards Genmab.
On this page we’ll provide you with information on how Genmab processes study subjects’ personal data when participating in a specific Genmab clinical trial. Please see the menu below.
| Clinical Trial Privacy Policies | |
|---|---|
| GCT1015-04 – International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) | Read |
| GCT1015-05 – International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) | Read |
| GCT1021-01 – Trial of Enapotamab Vedotin (HuMax®-AXL-ADC) | Read |
| GCT3013-03 – Trial of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) | Read |